Evolution in neuropsychiatric cis-regulatory enhancers through human-specific neuronal mutations within transcription factor binding sites.

Scientists studied genetic changes unique to humans that may affect brain development and increase risk for autism, schizophrenia, and bipolar disorder. They used computer modeling to see how these genetic changes affect how proteins control gene activity in the brain. The research suggests that genetic changes that helped human brains evolve may also make people more vulnerable to certain mental health conditions.

This computational study investigated human-specific genetic mutations in regulatory DNA regions that control gene expression in neuropsychiatric conditions including autism spectrum disorder, schizophrenia, and bipolar disorder. Researchers used molecular dynamic simulations to examine how these mutations affect the binding of transcription factors (proteins that regulate gene expression) to DNA enhancer regions. The study found evidence that human-specific mutations in these regulatory regions may have contributed to both human brain evolution and increased risk for psychiatric disorders. The research also identified signals of positive evolutionary selection in confirmed neuropsychiatric enhancers and analyzed how transcription factors bind differently to human-specific versus ancestral genetic variants.

This research provides insights into the evolutionary and genetic basis of neuropsychiatric disorders including autism. The identification of human-specific mutations in regulatory regions may inform future genetic screening approaches and help explain why certain psychiatric conditions are prevalent in humans compared to other species.

This appears to be a computational study using molecular simulations rather than experimental validation. Sample sizes and specific methodological details are not provided in the abstract. The clinical relevance of identified mutations requires further experimental confirmation.

cis-Regulatory elements (CREs) in multicellular genomes play a significant role in precise regulation of the genes. Increasing evidence has shown that alterations in CREs have had a drastic effect on the human brain evolution, neuronal cell adaptation and physiology. The human-specific sequence acceleration in CREs has not only changed the overall cognitive function of the human brain, but also seems to have strongly increased the risk of developing psychiatric disorders. Mapping the human-specific neuronal mutations within CREs remains to be a challenge and can largely impact the way DNA binding domain of the transcription factors interact with the CREs.

In this study, we have identified human-specific neuronal mutations within transcription factor binding sites in neuropsychiatric enhancers of three major psychiatric disorders i.e. autism spectrum disorder, schizophrenia and bipolar disorder and studied the impact of human-specific neuronal mutations on binding affinities with the respective transcription factors via molecular dynamic simulation. Moreover, we have also identified signals of positive selection in the same set of empirically confirmed neuropsychiatric enhancers and correlated it with the way transcription factors bind with the human-specific and their counterpart ancestral allele harboring transcription factor binding sites.